Literature DB >> 35794961

Use of Selective Serotonin Reuptake Inhibitors - Validity of Self-Report versus Plasma Concentrations and Pharmacy Dispensations - A Cross-Sectional Analysis of the Norwegian Women and Cancer Study.

Marit Waaseth1,2, Martina Havelkova1, Guro Forsdahl1, Eiliv Lund3, Tomas Log2,4.   

Abstract

Purpose: To validate self-reported current use of selective serotonin reuptake inhibitors (SSRI) in the Norwegian Women and Cancer study (NOWAC) and to identify factors associated with discordance between data sources. Material and
Methods: This is a cross-sectional record-linkage study comparing SSRI-use derived from four data sources: 1) Specific SSRI questions in the main NOWAC questionnaire, 2) Open questions on medication use in the small questionnaire following blood samples, 3) plasma concentration measurements for a subsample, and 4) pharmacy dispensations from the Norwegian prescription database (NorPD) where current use of SSRI was defined by Legend Time Duration (LTD). Among 105 855 women, aged 46 to 64 years and randomly selected from the general population, 70,191 had data on SSRI-use from both NOWAC and NorPD. Plasma concentration was measured for 93 pairs of self-reported SSRI-users and non-users, with dispensation data available for 68 pairs. Validity was assessed by sensitivity and specificity; agreement was assessed by Cohen's kappa. Factors associated with discordance between information sources were analyzed by multiple binary logistic regression.
Results: We found high sensitivity (89.5%) and specificity (98.7%) for the specific questions in the main questionnaire compared with pharmacy dispensations. Measured against plasma concentrations, current SSRI-use defined by open questions and pharmacy dispensations both had high sensitivity (100% and 92.5%, respectively) and specificity (98.6% both). Agreements (kappa) were similarly high for all comparisons (≥0.80). The factors associated with discordance between data sources included poor health, comorbidity, being single and not being in full time work. Education was inversely associated with discordance.
Conclusion: Self-reported current use of SSRI from the NOWAC questionnaires is highly valid and, according to plasma concentrations, perhaps even more so than pharmacy dispensations. Factors associated with discordance between information sources should be taken into account in the interpretation of future analyses which include SSRI-use in the NOWAC study.
© 2022 Waaseth et al.

Entities:  

Keywords:  agreement; antidepressants; pharmacy dispensations; plasma concentration; record linkage; self-report

Year:  2022        PMID: 35794961      PMCID: PMC9252190          DOI: 10.2147/CLEP.S366760

Source DB:  PubMed          Journal:  Clin Epidemiol        ISSN: 1179-1349            Impact factor:   5.814


  14 in total

Review 1.  Cohort profile: The Norwegian Women and Cancer Study--NOWAC--Kvinner og kreft.

Authors:  Eiliv Lund; Vanessa Dumeaux; Tonje Braaten; Anette Hjartåker; Dagrun Engeset; Guri Skeie; Merethe Kumle
Journal:  Int J Epidemiol       Date:  2007-07-20       Impact factor: 7.196

2.  Agreement between self-reported data on medicine use and prescription records vary according to method of analysis and therapeutic group.

Authors:  Merete Willemoes Nielsen; Birthe Søndergaard; Mette Kjøller; Ebba Holme Hansen
Journal:  J Clin Epidemiol       Date:  2008-05-12       Impact factor: 6.437

3.  Agreement between self-reported and pharmacy data on medication use in the Northern Finland 1966 Birth Cohort.

Authors:  Marianne Haapea; Jouko Miettunen; Sari Lindeman; Matti Joukamaa; Hannu Koponen
Journal:  Int J Methods Psychiatr Res       Date:  2010-06       Impact factor: 4.035

4.  Validation of pharmacy records in drug exposure assessment.

Authors:  H S Lau; A de Boer; K S Beuning; A Porsius
Journal:  J Clin Epidemiol       Date:  1997-05       Impact factor: 6.437

5.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

6.  Agreement between patient interview data on prescription medication use and pharmacy records in those aged older than 50 years varied by therapeutic group and reporting of indicated health conditions.

Authors:  Kathryn Richardson; Rose Anne Kenny; Jure Peklar; Kathleen Bennett
Journal:  J Clin Epidemiol       Date:  2013-08-19       Impact factor: 6.437

7.  External validity in a population-based national prospective study--the Norwegian Women and Cancer Study (NOWAC).

Authors:  Eiliv Lund; Merethe Kumle; Tonje Braaten; Anette Hjartåker; Kjersti Bakken; Elise Eggen; Torhild Inger Gram
Journal:  Cancer Causes Control       Date:  2003-12       Impact factor: 2.506

8.  A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women.

Authors:  Denise M Boudreau; Janet R Daling; Kathleen E Malone; Jacqueline S Gardner; David K Blough; Susan R Heckbert
Journal:  Am J Epidemiol       Date:  2004-02-01       Impact factor: 4.897

9.  The relationship between self-reported and registry-based data on use of psychoactive medications in postmenopausal women.

Authors:  Päivi H Rauma; Heli Koivumaa-Honkanen; Heikki Kröger; Marjo T Tuppurainen; Jussi Kauhanen; Risto J Honkanen
Journal:  BMC Psychiatry       Date:  2013-07-02       Impact factor: 3.630

10.  Concordance assessment of self-reported medication use in the Netherlands three-generation Lifelines Cohort study with the pharmacy database iaDB.nl: The PharmLines initiative.

Authors:  Rahmat Sediq; Jurjen van der Schans; Aafje Dotinga; Rolinde A Alingh; Bob Wilffert; Jens Hj Bos; Catharina Cm Schuiling-Veninga; Eelko Hak
Journal:  Clin Epidemiol       Date:  2018-08-16       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.